We also noted a difference in the gene expression outcome after RTX treatment with the MTX effects observed in our previous studies where the gene expression of ULK1, p21, and caspase 3 was still upregulated at the end of the follow-up period in blood from RA patients treated with MTX [26]. The gene discussed is CASP3; the disease is rheumatoid arthritis.